A newly characterized cathelicidin peptide from tiger frog skin (HR-CATH) demonstrates strong antimicrobial activity and can stimulate immune cell responses including chemotaxis and respiratory burst.
Dual-function peptideCombines direct pathogen killing with immune cell activation for enhanced defense
What the researchers found
Tiger frog cathelicidin HR-CATH combines direct antimicrobial activity (membrane disruption, DNA degradation) with immune-stimulating properties (macrophage chemotaxis and respiratory burst enhancement).
Why it matters
Antimicrobial peptides that both kill pathogens and boost immune responses are especially valuable as antibiotic alternatives, since they attack infections through multiple mechanisms that are harder for bacteria to resist.
The numbers in context
Active vs V. parahaemolyticus, S. aureus, A. hydrophila; LDH release confirmed membrane damage; dose-dependent DNA degradation; chemotaxis and respiratory burst in macrophages
How the study worked
cDNA cloning from skin transcriptome, chemical synthesis, in vitro antimicrobial testing, membrane integrity assays, DNA degradation assays, and immunomodulation testing in RAW264.7 macrophage cells.
Who was studied
In vitro testing against bacteria and RAW264.7 macrophage cell line
What this study cannot tell us
In vitro study only. No animal infection model tested. Peptide stability in vivo and therapeutic index not assessed. Limited to three bacterial species tested.
How to read the evidence
Well-characterized in vitro study with multiple activity assays. Early-stage evidence for a novel antimicrobial peptide.
When this study was published
Published in 2021, expanding the known diversity of amphibian cathelicidins.
The bigger picture
Amphibian skin is a rich source of antimicrobial peptides that have evolved over millions of years. Each new cathelicidin discovered expands the toolkit of potential antimicrobial compounds and reveals new structure-function relationships for peptide drug design.
Questions still open
- Would HR-CATH be effective against drug-resistant bacterial strains?
- How does its dual antimicrobial/immunomodulatory activity compare to human cathelicidin LL-37?
- Could HR-CATH or its derivatives be developed for clinical use?
Common questions
Why study frog skin for new medicines?
What makes this peptide special compared to other antibiotics?
Read the original research
Molecular characterization of cathelicidin in tiger frog (Hoplobatrachus rugulosus): Antimicrobial activity and immunomodulatory activity.
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 247, 109072
Citation
Chen, Jie; Lin, You-Fu; Chen, Jia-Hao; Chen, Xiang; Lin, Zhi-Hua. (2021). Molecular characterization of cathelicidin in tiger frog (Hoplobatrachus rugulosus): Antimicrobial activity and immunomodulatory activity.. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 247, 109072. https://doi.org/10.1016/j.cbpc.2021.109072